안과용 봉합사 시장 : 소재별, 흡수 특성별, 필라멘트 구조별, 용도별, 최종 사용자별, 유통 채널별 예측(2026-2032년)

The Ophthalmic Sutures Market is projected to grow by USD 780.93 million at a CAGR of 7.88% by 2032.

Ophthalmic Sutures Market Introduction

Ophthalmic sutures remain essential in eye surgery where wound security, tissue alignment, and controlled healing determine visual outcomes. These sterile microsutures are used across corneal repair, cataract complications, glaucoma procedures, keratoplasty, retinal surgery, oculoplastics, and ocular trauma management.

Demand is supported by a verified clinical burden: the World Health Organization reports that at least 2.2 billion people have near or distance vision impairment, with at least 1 billion cases considered preventable or yet to be addressed. Aging populations, diabetes-related eye disease, ocular trauma, and expanding access to specialty ophthalmic care continue to sustain the need for high-quality nylon, polypropylene, silk, polyester, and absorbable ophthalmic sutures.

Transformative Shifts in the Ophthalmic Sutures Landscape

The ophthalmic sutures landscape is shifting from volume-driven purchasing to procedure-specific selection. Smaller incisions, foldable intraocular lenses, microincision cataract surgery, and minimally invasive glaucoma surgery have reduced routine suturing in some procedures, but they have increased expectations for precision sutures when closure is required.

Manufacturers are responding with improved needle geometry, consistent tensile strength, finer gauges, low-tissue-drag coatings, atraumatic needle-suture combinations, and packaging that supports operating room efficiency. Hospitals and ambulatory surgery centers are also prioritizing sterility assurance, traceability, biocompatibility, and compliance with recognized medical device quality systems.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is influencing ophthalmic sutures indirectly but materially. AI-enabled imaging, surgical planning, and risk stratification help surgeons identify patients who may require reinforced closure, corneal stabilization, or specialized wound management after complex eye procedures.

AI also supports manufacturers through machine vision inspection, defect detection, process monitoring, demand forecasting, and inventory optimization. In clinical operations, predictive analytics can reduce stockouts of critical suture sizes such as 8-0, 9-0, 10-0, and 11-0, improving preparedness for high-acuity ophthalmic surgery while supporting more consistent operating room workflows.

Key Regional Insights

Asia-Pacific is a high-priority region for ophthalmic sutures due to large patient populations, cataract surgery programs, rising diabetic eye disease, and expanding ophthalmology infrastructure across China, India, Japan, South Korea, Australia, and ASEAN markets. North America benefits from advanced ophthalmic surgery centers, strong reimbursement pathways, surgeon specialization, and established medical device regulation that supports the adoption of precision microsurgical consumables.

Europe is shaped by Medical Device Regulation compliance, hospital procurement discipline, clinical documentation requirements, and aging demographics that sustain procedure volumes in cataract, glaucoma, corneal, and oculoplastic care. Latin America is expanding through private specialty clinics, cataract backlog reduction initiatives, and medical tourism in selected urban centers. The Middle East is supported by tertiary hospitals, investments in specialty care, and demand for premium imported devices, while Africa is advancing through public eye health programs, cataract outreach, trauma care needs, and partnerships that improve surgical access, although pricing, distribution reliability, and workforce availability remain uneven.

Key Group Insights

ASEAN demand is supported by cataract outreach, urban specialty hospitals, and growing private ophthalmology networks, particularly where governments and non-profit programs continue to address avoidable blindness. GCC markets prioritize premium imported medical devices, accredited hospitals, and advanced surgical infrastructure, while the European Union emphasizes regulatory compliance, clinical evidence, post-market surveillance, and supply chain transparency under harmonized medical device rules.

BRICS countries combine large ophthalmic patient pools with domestic manufacturing ambitions, public hospital purchasing, and expanding specialty surgical capacity. G7 markets lead in clinical standardization, surgeon training, advanced materials adoption, and premium microsurgical consumables. NATO members overlap significantly with developed procurement systems, where resilience, quality assurance, supplier continuity, and traceable sterile product supply are increasingly important for hospital systems and defense-linked healthcare readiness.

Key Country Insights

The United States leads in premium ophthalmic surgery adoption, subspecialty eye care, ambulatory surgical capacity, and use of advanced microsurgical consumables, while Canada emphasizes quality-controlled procurement and access through public and private care channels. Mexico and Brazil show demand from expanding private ophthalmology, cataract backlogs, ocular trauma care, and medical tourism pockets. The United Kingdom, Germany, France, Italy, and Spain prioritize regulatory compliance, hospital tenders, clinical governance, and aging-related procedure volumes, with Germany and France particularly influenced by structured hospital procurement and strong ophthalmology networks.

Russia maintains demand across urban surgical centers despite procurement complexity and supply chain constraints. China and India represent large-volume opportunities tied to cataract services, corneal care, diabetic eye disease, and public health efforts to reduce avoidable blindness. Japan and South Korea favor precision, advanced materials, surgeon preference consistency, and high-quality sterile packaging, while Australia benefits from high clinical standards, strong specialty care access, and established pathways for regulated medical devices.

Actionable Recommendations for Industry Leaders

Industry leaders should align product portfolios with procedure-specific needs, including nonabsorbable monofilament sutures for corneal and scleral applications and absorbable options for conjunctival and oculoplastic procedures. Clear labeling, consistent needle-suture attachment, reliable size availability, low memory, predictable knot security, and minimal tissue drag should be treated as commercial differentiators.

Companies should strengthen surgeon education, local distributor training, clinical evidence generation, and value messaging linked to sterility, handling, and procedural reliability. Investment in AI-assisted quality inspection, regional inventory analytics, tender readiness, and regulatory documentation can improve resilience while supporting hospital contracts, private surgery center adoption, and specialty ophthalmic procedure growth.

Research Methodology

This executive summary is based on secondary research from public health agencies, medical device regulatory frameworks, ophthalmology practice trends, hospital procurement patterns, peer-reviewed clinical knowledge, and manufacturer product literature. Key references include WHO vision impairment data, diabetes epidemiology from recognized health sources, and established surgical use cases for ophthalmic microsutures in corneal, cataract, glaucoma, retinal, and oculoplastic procedures.

Insights were synthesized through market segmentation by material, absorbability, gauge, needle type, procedure, end user, geography, and procurement environment. Emphasis was placed on verifiable drivers, regulatory context, and clinical adoption factors rather than unsupported market sizing, ensuring the analysis remains practical, evidence-led, and relevant to ophthalmic device stakeholders.

Conclusion

Ophthalmic sutures continue to occupy a critical role in eye surgery despite the growth of sutureless and minimally invasive techniques. The category is increasingly defined by precision, sterility, material performance, needle design, packaging integrity, and procedure-specific reliability rather than commodity purchasing alone.

Future competitiveness will depend on regulatory compliance, clinical education, supply continuity, surgeon trust, and integration with digital tools that improve forecasting and quality control. Companies that combine microsurgical performance with regional market discipline will be best positioned to address durable demand across cataract complications, corneal repair, glaucoma procedures, retinal surgery, oculoplastics, and ocular trauma care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Ophthalmic Sutures Market, by Material Type

• 7.1. Natural Sutures
  • 7.1.1. Silk
  • 7.1.2. Catgut
  • 7.1.3. Collagen
  • 7.1.4. Cotton
• 7.2. Synthetic Sutures
  • 7.2.1. Polyglactin
  • 7.2.2. Polyglycolic Acid
  • 7.2.3. Polydioxanone
  • 7.2.4. Nylon
  • 7.2.5. Polypropylene

8. Ophthalmic Sutures Market, by Absorption Profile

• 8.1. Absorbable Sutures
• 8.2. Non Absorbable Sutures

9. Ophthalmic Sutures Market, by Filament Structure

• 9.1. Monofilament Sutures
• 9.2. Multifilament Sutures
  • 9.2.1. Braided Sutures
  • 9.2.2. Twisted Sutures

10. Ophthalmic Sutures Market, by Application

• 10.1. Cataract
• 10.2. Corneal Transplantation
• 10.3. Glaucoma
• 10.4. Iridectomy
• 10.5. Vitrectomy
• 10.6. Refractive

11. Ophthalmic Sutures Market, by End User

• 11.1. Ambulatory Surgical Centers
• 11.2. Ophthalmic Clinics
• 11.3. Hospitals
• 11.4. Academic & Research Institutes

12. Ophthalmic Sutures Market, by Distribution Channel

• 12.1. Online
• 12.2. Offline

13. Ophthalmic Sutures Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Ophthalmic Sutures Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Ophthalmic Sutures Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Alcon Inc.
• 17.2. Assut Europe
• 17.3. Aurolab
• 17.4. B. Braun SE
• 17.5. Boz Medical
• 17.6. Corza Medical
• 17.7. DemeTECH Corporation
• 17.8. Dolphin Sutures
• 17.9. FCI Ophthalmics
• 17.10. GPC Medical Ltd.
• 17.11. Healthium Medtech Limited
• 17.12. Johnson & Johnson
• 17.13. Katsan TIbbi Cihazlar
• 17.14. Kono Seisakusho Co., Ltd.
• 17.15. Lotus Surgicals Pvt. Ltd.
• 17.16. Mani, Inc.
• 17.17. Medtronic plc
• 17.18. Meril Life Sciences Pvt. Ltd.
• 17.19. Orion Sutures India Private Limited
• 17.20. Peters Surgical
• 17.21. SMI AG
• 17.22. Surgiwear Ltd.
• 17.23. Teleflex Incorporated
• 17.24. Unilene SAC